Literature DB >> 21600669

Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.

Joe H Chang1, Daryl Lim Joon, Sze Ting Lee, Sylvia J Gong, Andrew M Scott, Ian D Davis, David Clouston, Damien Bolton, Christopher S Hamilton, Vincent Khoo.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the accuracy of (11)C-choline PET scans in defining dominant intraprostatic lesions (DILs) for radiotherapy target volume definition.
MATERIAL AND METHODS: Eight men with prostate cancer who had (11)C-choline PET scans prior to radical prostatectomy were studied. Several methods were used to contour the DIL on the PET scans: visual, PET Edge, Region Grow, absolute standardised uptake value (SUV) thresholds and percentage of maximum SUV thresholds. Prostatectomy specimens were sliced in the transverse plane and DILs were delineated on these by a pathologist. These were then compared with the PET scans. The accuracy of correlation was assessed by the Dice similarity coefficient (DSC) and the Youden index.
RESULTS: The contouring method resulting in both the highest DSC and the highest Youden index was 60% of the maximum SUV (SUV(60%)), with values of 0.64 and 0.51, respectively. However SUV(60%) was not statistically significantly better than all of the other methods by either measure.
CONCLUSIONS: Although not statistically significant, SUV(60%) resulted in the best correlation between (11)C-choline PET and pathology amongst all the methods studied. The degree of correlation shown here is consistent with previous studies that have justified using imaging for DIL radiotherapy target volume definition.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600669     DOI: 10.1016/j.radonc.2011.03.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.

Authors:  Tony Shepherd; Mika Teras; Reinhard R Beichel; Ronald Boellaard; Michel Bruynooghe; Volker Dicken; Mark J Gooding; Peter J Julyan; John A Lee; Sébastien Lefèvre; Michael Mix; Valery Naranjo; Xiaodong Wu; Habib Zaidi; Ziming Zeng; Heikki Minn
Journal:  IEEE Trans Med Imaging       Date:  2012-06-04       Impact factor: 10.048

2.  Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.

Authors:  Yu Kuang; Lili Wu; Emily Hirata; Kyle Miyazaki; Miles Sato; Sandi A Kwee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

3.  Effect of androgen deprivation therapy on intraprostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.

Authors:  Joachim Chan; Antony Carver; John N H Brunt; Sobhan Vinjamuri; Isabel Syndikus
Journal:  Br J Radiol       Date:  2016-12-20       Impact factor: 3.039

4.  Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.

Authors:  Cédric Draulans; Robin De Roover; Uulke A van der Heide; Linda Kerkmeijer; Robert J Smeenk; Floris Pos; Wouter V Vogel; James Nagarajah; Marcel Janssen; Sofie Isebaert; Frederik Maes; Cindy Mai; Raymond Oyen; Steven Joniau; Martina Kunze-Busch; Karolien Goffin; Karin Haustermans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-06       Impact factor: 9.236

5.  Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.

Authors:  Escarlata López; Antonio Lazo; Antonio Gutiérrez; Gregorio Arregui; Isabel Núñez; Antonio Sacchetti
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-16

6.  11C-Choline PET/pathology image coregistration in primary localized prostate cancer.

Authors:  Anca-Ligia Grosu; Gregor Weirich; Christina Wendl; Vesna Prokic; Simon Kirste; Hans Geinitz; Michael Souvatzoglou; Juergen E Gschwend; Markus Schwaiger; Michael Molls; Wolfgang A Weber; Uwe Treiber; Bernd Joachim Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-04       Impact factor: 9.236

7.  Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?

Authors:  L Van den Bergh; S Isebaert; M Koole; R Oyen; S Joniau; E Lerut; C M Deroose; F De Keyzer; H Van Poppel; K Haustermans
Journal:  Strahlenther Onkol       Date:  2013-09       Impact factor: 3.621

8.  Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.

Authors:  Joe H Chang; Daryl Lim Joon; Sze Ting Lee; Chee-Yan Hiew; Stephen Esler; Sylvia J Gong; Morikatsu Wada; David Clouston; Richard O'Sullivan; Yin P Goh; Henri Tochon-Danguy; J Gordon Chan; Damien Bolton; Andrew M Scott; Vincent Khoo; Ian D Davis
Journal:  Eur Radiol       Date:  2013-11-06       Impact factor: 5.315

9.  MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.

Authors:  Constantinos Zamboglou; Gesche Wieser; Steffen Hennies; Irene Rempel; Simon Kirste; Martin Soschynski; Hans Christian Rischke; Tobias Fechter; Cordula A Jilg; Mathias Langer; Philipp T Meyer; Michael Bock; Anca-Ligia Grosu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-23       Impact factor: 9.236

Review 10.  Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.

Authors:  S M Schwarzenböck; J Kurth; Ch Gocke; T Kuhnt; G Hildebrandt; B J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.